J. Metges
AuthID: R-00J-2B8
1
TITLE: The phase 3 KEYNOTE-181 study: pembrolizumab versus chemotherapy as second-line therapy for advanced esophageal cancer
AUTHORS: Metges, J; Francois, E; Shah, M; Adenis, A; Enzinger, P; Kojima, T; Muro, K; Bennouna, J; Hsu, C; Moriwaki, T; Kim, S; Lee, S; Kato, K; Shen, L; Qin, S; Ferreira, P; Wang, R; Bhagia, P; Kang, S; Doi, T;
PUBLISHED: 2019, SOURCE: European-Society-for-Medical-Oncology (ESMO) 21st World Congress on Gastrointestinal Cancer in ANNALS OF ONCOLOGY, VOLUME: 30
AUTHORS: Metges, J; Francois, E; Shah, M; Adenis, A; Enzinger, P; Kojima, T; Muro, K; Bennouna, J; Hsu, C; Moriwaki, T; Kim, S; Lee, S; Kato, K; Shen, L; Qin, S; Ferreira, P; Wang, R; Bhagia, P; Kang, S; Doi, T;
PUBLISHED: 2019, SOURCE: European-Society-for-Medical-Oncology (ESMO) 21st World Congress on Gastrointestinal Cancer in ANNALS OF ONCOLOGY, VOLUME: 30
INDEXED IN: 
WOS
WOS